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To infer the causal association between childhood BMI and age at menarche, we performed a mendelian randomisation analysis
using twelve established “BMI-increasing” genetic variants as an instrumental variable (IV) for higher BMI. In 8,156 women of
European descent from the EPIC-Norfolk cohort, height was measured at age 39–77 years; age at menarche was self-recalled, as
was body weight at age 20 years, and BMI at 20 was calculated as a proxy for childhood BMI. DNA was genotyped for twelve BMI-
associated common variants (in/near FTO,MC4R, TMEM18, GNPDA2, KCTD15, NEGR1, BDNF, ETV5,MTCH2, SEC16B, FAIM2
and SH2B1), and for each individual a “BMI-increasing-allele-score” was calculated by summing the number of BMI-increasing
alleles across all 12 loci. Using this BMI-increasing-allele-score as an instrumental variable for BMI, each 1 kg/m2 increase in
childhood BMI was predicted to result in a 6.5% (95% CI: 4.6–8.5%) higher absolute risk of early menarche (before age 12 years).
While mendelian randomisation analysis is dependent on a number of assumptions, our findings support a causal eﬀect of BMI
on early menarche and suggests that increasing prevalence of childhood obesity will lead to similar trends in the prevalence of early
menarche.
1. Introduction
Early age at menarche, the onset of menstrual periods in
girls, is associated with increased risks of adverse health
outcomes such as breast, ovarian, and endometrial cancer,
hypertension, type 2 diabetes, and cardiovascular disease [1,
2]. Earlier age at menarche is also associated with increased
risk for a number of psychosocial outcomes in adolescence
including depression, eating disorders, substance abuse,
sexual risk-taking and teenage pregnancy [3].
It has been suggested that childhood BMI has a causal
eﬀect on the risk for early menarche and there are a number
of strongly plausible biological mechanisms [4, 5]. However,
discordant secular trends in obesity and age atmenarche have
raised doubts about the causal nature of these associations.
In developed countries, a long-term trend towards earlier
menarche has been observed from the late 1800s to the
mid 1900s [6]. In many countries these trends appear to
have slowed or even stopped since around 1950 [6] while
the prevalence of childhood overweight and obesity has
increased since the 1980s [7]. It is possible, therefore, that
the apparent association between higher BMI and earlier age
at menarche might be confounded by other factors such as
diet or exposure to endocrine disruptors [8]. The association
could also be explained by reverse causality as the progression
of puberty in girls is accompanied by rapid gains in body
weight and body fat [9].
Mendelian randomisation, using robust genetic vari-
ants as “instrumental variables” [10], has been suggested
as an approach to avoid the problems of confounding,
residual confounding and specificity that are experienced
by traditional epidemiological studies [11]. For example,
Mendelian randomisation studies have demonstrated the
causal eﬀects of low-density lipoprotein (LDL) cholesterol
on risk of myocardial infarction [12], apparent protective
eﬀects of high-density lipoprotein (HDL) cholesterol on
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coronary heart disease [13], and lack of a causal eﬀect of C-
reactive protein (CRP) on ischemic cerebrovascular disease
and carotid intimamedia thickness [14]. Similar approaches,
using BMI-increasing variants at FTO and MC4R have
reported apparent causal eﬀects of BMI on hypertension [15]
and markers of atherosclerosis [16]. In recent years, large
scale genome wide association (GWA) studies have identified
several common genetic variants that are robustly associated
with increased BMI [17–20]. Furthermore, two large studies
have reported that some of these genetic variants for higher
BMI are also associated with earlier age at menarche [21, 22].
We therefore used a mendelian randomisation approach to
assess the likely causal nature of the observed association
between higher BMI and risk of early menarche [11].
2. Materials and Methods
2.1. The EPIC-Norfolk Study. The European Prospective
Investigation into Cancer and Nutrition-(EPIC-) Norfolk
study is a large, predominantly ethnically homogenous,
white European population-based cohort study, which is part
of a multicentre international study designed to investigate
the relationship between diet and chronic disease. The design
of the EPIC-Norfolk study has been described in detail
previously [23]. The EPIC-Norfolk study was approved by
the Norwich local research ethics committee and informed
consent was given by all participants.
Age at menarche in completed whole years and weight
at age 20 years were ascertained by recall in the baseline
questionnaire which women completed at age 39–77 years
old. Weight at age 20 was recalled and adult height measured
at baseline by trained nurses. The measures were used to
calculate BMI at age 20 (recalled weight in kg divided by
height squared in metres). This was used as a proxy for
childhood BMI. Genotype information was available for
12 variants in the first 12 loci that were identified in the
first three waves of GWA studies for BMI [17–20]; these
variants were rs91121980 (in/near to gene FTO); rs17782313
(MC4R), rs6548238 (TMEM18), rs10938397 (GNPDA2),
rs368794 (KCTD15), rs32568958 (NEGR1), rs10838738
(MTCH2), rs925946 (BDNF), rs7498665 (SH2B1),
rs10913469 (SEC16B), rs10938397 (FAIM2/BCDIN3D) and
rs7647305 (ETV5). Genotyping was performed by custom
TaqMan SNP Genotyping Assays (Applied Biosystems,
Warrington, UK) or (markers rs10938397 and rs10838738)
Sequenom iPLEX Gold standard chemistry (Sequenom, San
Diego, CA) as previously described [24]. Call rates were
>95% and each locus genotyped was under HW equilibrium
given α = 0.05.
In the EPIC-Norfolk study, 10,957 women had DNA
available for genotyping. Of these, only 6,709 women had
complete genotype data on all 12 SNPs, however a further
3,972 women had genotype data on at least 9 SNPs and for
these women we imputed genotype data on their missing
(up to 3) SNPs using the mean number of BMI-increasing
alleles at each SNP as the individual values (we excluded 276
women who lacked genotype data on more than 3 SNPs).
Of the 10,681 women with complete or imputed genotype
data, 10,136 had data on recalled age at menarche within the
physiological range of 8–18 years, and of these 8,387 women
had data on their recalled body weight at age 20 years, and
8,156 also had data on measured height in order to calculate
BMI at age 20. All analyses were therefore based on 8,156
women, who were slightly younger, taller and lighter at their
baseline visit compared to excluded women, but had very
similar recalled weight and (calculated) BMI at age 20 and
recalled age at menarche (Table 1).
2.2. Statistical Analyses
2.2.1. Mendelian Randomisation. The outcome variable
“early menarche” was defined as menarche before age 12
years, as previously described [25, 26]. As the association of
interest was between prepubertal BMI and age at menarche,
BMI at age 20 years was used as a proxy for prepubertal BMI.
The directly observed increase in risk of early menarche per
1 kg/m2 change in BMI at age 20 was assessed by logistic
regression (to estimate an odds ratio), and by binomial
regression (to estimate an absolute increase in risk), with
adjustment for age at baseline.
To represent an instrumental variable (IV) for higher
BMI, a “BMI-increasing-allele-score” was created in EPIC-
Norfolk by summing the number of BMI-increasing alleles
across all 12 loci in each person. The association between the
BMI-increasing-allele-score and BMI at age 20 was analysed
by linear regression, with adjustment for age at baseline. The
association between the BMI-increasing-allele-score and risk
of early menarche was analysed by logistic regression.
The IV-predicted risk for early menarche per 1 kg/m2
change in BMI and was calculated using the ivprobit
command in STATA with a maximum likelihood estimator
in order to calculate the predicted absolute risk probabilities.
All analyses were conducted using STATA version 10.1
StataCorp., College Station, TX).
3. Results
3.1. The BMI-Increasing-Allele-Score. Associations between
the individual variants and BMI at age 20 years in EPIC-
Norfolk women are shown in Table 2. All 12 variants showed
directionally consistent associations with BMI at age 20
as expected from the original reports [17–20]. The BMI-
increasing-allele-score ranged from 3 to 20 alleles and was
normally distributed (Figure 1). Because few women had a
score below 6 (n = 51) or above 17 (n = 25) in Figure 1
these scores were collapsed into the categories: “less than or
equal to 6” and “greater than or equal to 17” and imputed
SNP counts were rounded to the nearest whole number for
the figure. On average, each additional BMI-increasing allele
was associated with 0.12 kg/m2higher BMI at age 20 (95%CI:
0.10–0.15, P = 6.8× 10−19), but showed no association with
adult height (P = .3).
3.2. Mendelian Randomisation. 1,766 (21.7%) EPIC-Norfolk
women reported that their menarche occurred before age 12
years (early menarche). Each 1 kg/m2 higher BMI at age 20
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Table 1: Characteristics of EPIC-Norfolk women included in the current study.
Included women Excluded women
n Mean SD n Mean SD ∗P value
Age at baseline visit (years) 8,156 58.2 9.2 2,801 59.8 9.3 <.001
Height at baseline visit (cm) 8,156 161.1 6.2 2,503 160.5 6.2 <.001
Weight at baseline visit (kg) 8,150 67.6 11.5 2,510 68.3 12.1 .004
Weight at age 20 (kg) 8,156 56.8 8.0 804 56.5 7.8 .2
BMI at age 20 (kg/m2) 8,156 21.9 2.8 559 21.7 2.6 .2
Age at menarche (years) 8,156 13.0 1.6 2,241 13.0 1.6 .04
Inclusion criteria were complete genotype data on at least 9 SNPs, available height measurement and recalled information on age at menarche between 8 to
18 years, and body weight at age 20 years.
∗P values for unpaired t-test.
Table 2: Associations between individual BMI-increasing variants and BMI at age 20 years in 8,156 EPIC-Norfolk women.
Nearby gene SNP Chromosome Position B∗ (kg/m2/allele) Lower CI Upper CI
SEC16B rs10913469 1 176180142 0.28 0.17 0.38
TMEM18 rs6548238 2 624905 0.21 0.10 0.32
FTO rs1121980 16 52366748 0.20 0.11 0.29
FAIM2 rs7132908 12 48549415 0.15 0.06 0.23
BDNF rs925946 11 27623778 0.13 0.03 0.22
MC4R rs17782313 18 56002077 0.13 0.03 0.23
GNPDA2 rs10938397 4 45023455 0.10 0.01 0.19
SH2B1 rs7498665 16 28790742 0.09 0.00 0.18
NEGR1 rs2568958 1 72477137 0.08 −0.01 0.16
ETV5 rs7647305 3 187316992 0.08 −0.03 0.18
MTCH2 rs10838738 11 47619625 0.08 −0.02 0.17
KCTD15 rs368794 19 39012292 0.06 −0.03 0.15
∗
B: regression coeﬃcient from additive genetic models for the previously reported BMI-increasing allele.
12.4
12.6
12.8
13
13.2
13.4
M
ea
n
ag
e
at
m
en
ar
ch
e
(y
ea
rs
)
0
200
400
600
800
1000
1200
N
u
m
be
r
of
w
om
en
7 8 9 10 11 12 13 14 15 16
Number of BMI-increasing alleles
≤6 ≥17
Figure 1: Histogram showing the distribution of the BMI-
increasing-allele-score in EPIC-Norfolk women (n = 8, 156).
Within each allele score category, the mean and 95% CI for age at
menarche are shown by circles and error bars. The trend line shows
the inverse linear trend between mean age at menarche and allele
score category.
was directly associated with an 11% (95% CI: 9–14%) higher
relative risk of early menarche, or in terms of absolute risk
1.7% higher (1.5 to 2.0%).
The BMI-increasing-allele-score was positively associ-
ated with the relative risk of early menarche (OR = 1.06 per
allele, 95% CI =1.03–1.08, P = 5.8× 10−6). When using the
BMI-increasing-allele-score as an instrumental variable for
BMI, each 1 kg/m2 increase in BMI at age 20 was predicted to
result in a 6.5% (95% CI: 4.6–8.5%) increase in the absolute
risk of early menarche.
We performed a sensitivity analysis by calculating a
“weighted BMI-increasing-allele-score”, where the contri-
bution of each genotype to the score was weighted by
its individual association with BMI at age 20. Using this
weighted BMI-increasing-allele-score, each 1 kg/m2 increase
in BMI at age 20 was predicted to result in a 6.7% (95% CI:
5.0–8.4%) higher absolute risk of early menarche.
4. Discussion
The results of this mendelian randomisation analysis infers a
causal eﬀect of higher BMI on increased risk of early menar-
che (at age <12 years), and that the observed association
is unlikely to be explained by positive confounding or by
reverse causality.
It is not suggested that such genetic instrumental variable
approaches can replace randomised controlled trials, but
rather that they support the causal inference from obser-
vational studies. This is because mendelian randomisation
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Table 3: Longitudinal studies reporting the association between childhood BMI and subsequent age at menarche.
Reference
(country)
Number of
participants
Mean age at
BMI assessment
Mean age at
followup
Findings
Ong et al. 2009
(UK) [33] 1,781
9 mo
19 mo
13 y
Mean ± SE BMI by age at menarche
<12 y 12-13 y >13 y
P value
for trend
(i) 9 mo 17.5 ± 0.1 17. 3 ± 0.1 17.3 ± 0.1 .007
(ii) 19 mo 16.9 ± 0.1 16.7 ± 0.1 16.7 ± 0.1 .09
Buyken et al. 2009
(Germany) [34]
87
7.7 y
(Interquartile
range 6.5–8.8)
13 y
Age at menarche (mean, 95% CI) by BMI z-score 1 year before
height “take-oﬀ”
(i) Lowest BMI quartile 12.9 y (12.4–13.4)
P value
for trend
(ii) Quartiles 2 and 3 11.7 y (11.4–12.1) .03
(iii) Highest BMI quartile 12.4 y (11.9–12.8)
Lee et al. 2007
(USA) [36]
354
3.0 y
4.5 y
6-7 y
12 y
Odds ratio (95% CI) for early menarche (by age 12 y) per +1 BMI
z-score
(i) 3.0 y OR = 1.45 (1.10–1.93)
(ii) 4.5 y OR = 1.50 (1.14–1.97)
(iii) 6-7 y OR = 1.85 (1.38–2.47)
Must et al. 2005
(USA) [35]
307
12.0 y
(SD 1.2)
15 y
Age at menarche showed an inverse trend with premenarche BMI
Correlation coeﬃcient = −0.10; P = .08.
Freedman et al.
2003 (USA) [31]
771 Whites
408 Blacks
8.7 y (SD 2)
whites
8.9 y (SD 2)
blacks
17 y
Odds ratio (95% CI) for early menarche (<12 y) per +1 BMI z-score
White girls OR = 2.0 (1.6–2.5)
Black girls OR = 2.1 (1.5–3.0)
relies on several assumptions [11]. Firstly, that there is a
reliable association between the genetic variant and the expo-
sure, childhood BMI. While we did not have information on
childhood BMI in this study, the eﬀect size of our 12-variant
BMI-increasing-allele-score on BMI at 20 years (+0.12 kg/m2
per allele, or around 0.04 of an SD) is identical to that in
9–15-year-old children with research clinic measurements
in the European Youth Heart Study (0.04 SD per allele;
n = 2, 042 children) [27], and is similar to the eﬀect
size of a 10-variant score at age 9 years in the ALSPAC
study (BMI: 0.07 SD per allele; weight 0.05 SD per allele
[28]. We are therefore confident that our genetic score is
a valid instrumental variable for childhood BMI. Secondly,
the genetic variants should not have pleiotropic eﬀects on
diﬀerent biological processes, or be in linkage disequilibrium
with other genetic variants that might directly aﬀect the
outcome [11]. We would expect that pleiotropic eﬀects (i.e.,
mediated by independent biological processes) on BMI and
timing of menarche are infrequent among BMI variants. In
contrast, a recent very large study in 87,000 women reported
that individually 9 of the 12 BMI-increasing variants that
we studied here showed significant associations with lower
age at menarche [29]. As most BMI-increasing variants are
associated with lower age at menarche, we consider that
pleiotropy is unlikely and therefore our findings indicate
a causal pathway linking higher BMI, or the growth and
developmental processes that lead to higher BMI, to earlier
menarche.
It is unclear why our IV-predicted association, based
on the genetic score, was even stronger than the directly
observed association between BMI and early menarche. The
mechanisms of action for these variants are yet unknown and
it is possible that somemight indeed have direct eﬀects on the
timing of menarche. Alternatively, the observed association
between childhood BMI and age at menarche might have
been artificially diminished due to negative confounding or
due to our imprecise estimate of childhood BMI. In this case,
the IV-predicated association may actually be closer to true
size of the causal association between childhood BMI and age
at menarche.
The lack of direct assessments of growth during child-
hood was a limitation of our study. Recalled body weight
at age 20 years was used to calculate a proxy measure of
childhood BMI. However, other studies have demonstrated
that recall of early adult weight in this age group is reliable
[30] and that BMI at age 20 is well-correlated with childhood
BMI [31]. Furthermore in our IV analyses, BMI at 20 is only
used in order to estimate the eﬀect size of the genetic score on
childhood BMI, and the result was very similar to that found
in earlier childhood studies (discussed above).
Our inference of a causal relationship between higher
BMI and early menarche is supported by other sources
of evidence. One randomised control trial showed that
reduction in childhood obesity led to avoidance of early
menarche [32]. However, the lifestyle intervention used in
that trial lead to changes in fruit and vegetable consumption,
duration of physical activity and sedentary behaviour, and it
is therefore not possible to specify any one causal factor. Most
longitudinal studies, while small in numbers, consistently
report that higher BMI during childhood is associated with
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subsequent increased risk of early menarche [31, 33–36]
(Table 3). In those longitudinal studies, associations with
earlier menarche were seen with childhood BMI at various
ages from 9 months through to 12 years. One study reported
that greater weight gain even in the first weeks andmonths of
life was associated with earlier age at menarche [33]. Further
longitudinal studies are needed to identify the relative eﬀects
of rapid weight during diﬀerent childhood ages, up to and
including the pubertal years, on the timing of menarche.
In a separate birth cohort study [37] we recently exam-
ined the relationship between the age at menarche genetic
variant in LIN28B to measures of growth and weight gain
from birth to age 53 years. In that study, that the menarche-
lowering allele was associated with higher BMI in women
from ages 15–43 years, but not before age 15. That finding is
therefore consistent with our current analysis in supporting
a causal direction of childhood BMI on puberty timing,
although puberty timing may in turn influence BMI beyond
puberty.
Together, these findings indicate that the occurrence of
early menarche is likely to increase as the prevalence of
childhood overweight and obesity increases. An expert panel
assembled to assess the evidence for an ongoing secular trend
in age at menarche since 1940 failed to reach a consensus,
although the majority concluded that there was suﬃcient
evidence for an ongoing decline [6]. The rapid reductions in
mean age at menarche from the late 1800s to the mid 1900s
have been attributed to the avoidance of under-nutrition,
while the eﬀects of overnutrition on further advancing age
at menarche may result in relatively slower yet continuing
trends to earlier menarche [38].
5. Conclusions
Our genetic IV analysis infers a strong causal eﬀect of
higher childhood BMI on the risk of early menarche.
While mendelian randomisation analysis is dependent on
a number of assumptions, our conclusions are supported
by the findings of longitudinal studies and suggest that
increasing trends in childhood obesity will lead to increasing
prevalence of early menarche.
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